이상반응 보고
| VAERS ID | 1529853 |
|---|---|
| 성별 | 여성 |
| 나이 | 34세 |
| 주 코드 | FR |
| 제약회사 | MODERNA |
| 로트 번호 | |
| 예방접종 횟수 | 1 |
| 접종일 | 2021-07-27 |
| 발병일 | 2021-07-28 |
| 상태 |
증상
- 구토(Vomiting)
- 림프절병증(Lymphadenopathy)
- 임신 중 모성 노출(Maternal exposure during pregnancy)
이환 중 질병
Pregnancy
지병
기타 의료
FOLIC ACID
이전 예방접종
알레르기
임상 검사
증상 상세
Maternal exposure during pregnancy; Swollen lymph nodes; Vomiting; This regulatory authority prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy), LYMPHADENOPATHY (Swollen lymph nodes) and VOMITING (Vomiting) in a 34-year-old female patient who received mRNA-1273 (Moderna CoviD-19 Vaccine) for COVID-19 vaccination.
Concurrent medical conditions included Pregnancy.
Concomitant products included FOLIC ACID for Folic acid supplementation.
On 27-Jul-2021, the patient received second dose of mRNA-1273 (Moderna CoviD-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form.
On an unknown date, the patient received first dose of mRNA-1273 (Moderna CoviD-19 Vaccine) (unknown route) 1 dosage form.
Last menstrual period and estimated date of delivery were not provided.
On 28-Jul-2021, the patient experienced LYMPHADENOPATHY (Swollen lymph nodes) (seriousness criterion medically significant) and VOMITING (Vomiting) (seriousness criterion medically significant).
On an unknown date, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) (seriousness criterion medically significant).
The delivery occurred on an unknown date.
At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) outcome was unknown, LYMPHADENOPATHY (Swollen lymph nodes) was resolving and VOMITING (Vomiting) had not resolved.
The action taken with mRNA-1273 (Moderna CoviD-19 Vaccine) (Unknown) and mRNA-1273 (Moderna CoviD-19 Vaccine) (Intramuscular) was unknown.
Treatment medication was not provided.
The patient was exposed to the vaccine in the third-trimester (29-40 weeks).
No treatment information was reported.
This is a case of product exposure during pregnancy for Moderna mRNA-1273 (unknown lot#) for this 34-year-old female with associated adverse events of Lymphadenopathy and vomiting as reported.
Very limited information regarding these events have been provided at this time.
Seriousness criteria for the events was captured by regulatory authority, however based on medical judgement the case is non serious.
No further information is expected.
; Sender's Comments: This is a case of product exposure during pregnancy for Moderna mRNA-1273 (unknown lot#) for this 34-year-old female with associated adverse events of Lymphadenopathy and vomiting as reported.
Very limited information regarding these events have been provided at this time.
Seriousness criteria for the events was captured by regulatory authority, however based on medical judgement the case is non serious.
No further information is expected.